Lv4
760 积分 2022-07-22 加入
A durably colonising engineered native symbiont enables sustained intestinal delivery for metabolic dysfunction and colitis
2天前
已完结
Faecal phageome transplantation alleviates intermittent intestinal inflammation in IBD and the timing of transplantation matters: a preclinical proof-of-concept study in mice
9天前
已完结
Engineering a Single-Agent Cytokine/Antibody Fusion That Selectively Expands Regulatory T Cells for Autoimmune Disease Therapy
15天前
已完结
An IL-2 mutein engineered to promote expansion of regulatory T cells arrests ongoing autoimmunity in mice
18天前
已完结
Rewiring STAT signaling from the cell surface with Trikine immunotherapeutics
19天前
已完结
Structure-based decoupling of the pro- and anti-inflammatory functions of interleukin-10
19天前
已完结
Risk of serious infections in patients with inflammatory bowel disease treated with biologic and small molecule therapies: a nationwide cohort study
1个月前
已完结
IDDF2025-ABS-0375 Efficacy and safety of upadacitinib in difficult-to-treat inflammatory bowel disease: a multicenter, prospective, real-world study (easeupibd study)
1年前
已完结
IDDF2025-ABS-0300 Infliximab versus glucocorticoids as first-line therapy for moderate-to-severe ulcerative colitis: a multicenter, prospective, parallel-controlled, real-world cohort study (insure study)
1年前
已完结
IDDF2025-ABS-0375 Efficacy and safety of upadacitinib in difficult-to-treat inflammatory bowel disease: a multicenter, prospective, real-world study (easeupibd study)
1年前
已关闭
皖公网安备34019202002308
